EVGN logo

Evogene Ltd. Stock Price

TASE:EVGN Community·₪31.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

EVGN Share Price Performance

₪3.58
-2.19 (-37.95%)
₪3.58
-2.19 (-37.95%)
Price ₪3.58

EVGN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with excellent balance sheet.

6 Risks
3 Rewards

Evogene Ltd. Key Details

US$8.0m

Revenue

US$2.8m

Cost of Revenue

US$5.2m

Gross Profit

US$15.9m

Other Expenses

-US$10.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.23
65.01%
-133.31%
0%
View Full Analysis

About EVGN

Founded
1999
Employees
117
CEO
Ofer Haviv
WebsiteView website
www.evogene.com

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Recent EVGN News & Updates

Recent updates

No updates